AIM Breakfasts

AIM BREAKFAST – 19th August 2016

Set Menu AIM:

Total number of AIM Companies (Incl Susp): 1,006

Total number of AIM Companies trading: 990*
* As at 16 August 2016

Dish of the Day:

AEC Education (AEC.L)  to resume trading on AIM following publication of Annual Report

Off the Menu:

Stellar Diamonds (STEL.L) suspended pending potential reverse takeover

Set Menu ISDX Growth:

Total number of ISDX Growth Market Companies (Incl Susp): *

Total number of ISDX Growth Market Companies trading: *
* As at 16 August 2016

Dish of the Day:

Off the Menu:

What’s Cooking in the IPO Kitchen?

LoopUp—The provider of conference calls and online meetings is seeking to join AIM. 2015 revs of £9.2m and EBITDA of £1.02m

Bacanora Lithium— To list on AIM around 30 Sep as holding company for TSX listed Bacanora Minerals at £100m market cap

Aura Energy—ASX listed uranium developer (ASX:AEE) expected to join AIM 6 September

Autins Group plc – The acoustic and thermal insulation specialist now looks to join AIM late August

 

Breakfast Buffet

Polo Resources (POL.L) 6.22p £19.4m

Polo’s investee company, Blackham Resources (ASX: BLK) has raised approximately A$25 million through a placement of approximately 25 million new shares at a price of A$1.00 per share (2% discount) to fast track expansion plans.

The Placement proceeds will be used at Blackham’s 100% owned 5.1Moz Matilda Gold Project. Blackham reports that Matilda gold production is targeted within 3 weeks.

 

Immedia Group (IME.L) 33.5p £4.9m

The supplier of digital audio content solutions for leading brands and global businesses, announces that its contract with Arcadia Group Ltd will expire in December 2016. Conversely it is seeing significantly higher than expected uptake of SUBWAY® Radio by franchisees The Board  expects uptake to further accelerate into the next financial year as the service is rolled out across existing stores and new franchises are opened. Advanced negotiations for substantive deal with Major UK Retailer.

 

PHSC (PHSC.L) 27p £3.5m

The provider of health, safety, hygiene and environmental consultancy services and security solutions to the public and private sectors, announce that, in response to investor demand communicated to it yesterday, it has raised £350,000 through a placing  with new investors at a price of 22p per share, an 18.5% discount to yesterday’s closing mid price. The funds will provide PHSC with additional working capital including for ongoing expenditure relating to recent acquisitions.

 

Inspiration Healthcare(IHC.L) 60p £18.4m

The global medical device company  has proposed a reduction of its share premium account in order to create distributable reserves to provide the Board with the flexibility to distribute profits to shareholders as dividends, subject to the financial performance of the Company. FY Jan2017E numbers are looking for £14.3m revenue and £1.2m PBT. The company reported cash balances of £2.3m at the last year end.

 

Kellan Group (KLN.L) 1.25p £4.25m

The recruitment business operating across a wide range of functional disciplines and industry sectors reported H1Jun interims. Net Fee Income fell 10% to £3.3m. Adjusted EBITDA £0.2m vs £0.4m. Berkeley Scott’s temporary business was flat 0with the new Living Wage impacting H1 performance. Construction growing. ‘Uncertainty surrounding the EU referendum has been a distraction in H1 of 2016’  ‘We have also seen some general slowness post referendum in job flow and candidate attraction. ‘

 

Mincon Group (MCON.L) 56p £117.9m

The Irish engineering group specialising in the design, manufacture, sale and servicing of rock drilling tools and associated products has reported H1Jun 16 interims. Revenue for H1 was 11% ahead of last year at €36.3 million, which tracked through to an improvement of 11% in profit before tax to €5.0 million against the backdrop of the cyclically depressed volumes and margins in some of the sectors Mincon services. Market share increasing. Some improvements in commodity prices/end-markets. 17x PE.

 

Netscientific (NSCI.L) 181.5p £39.3m

The transatlantic biomedical and healthcare technology group, announced that its digital health portfolio company, Wanda has launched myWanda, the first and only mobile application aimed at empowering women to improve the health of their hearts. Available on US iTunes. Forecasts for FY2016E are looking for £0.73m revenues and a £14.98m pre-tax loss.

 

Fox Marble Holdings (FOX.L) 9.38p £16.9m

The company focused on marble quarrying & finishing in Kosovo and the Balkans region, announced an operational update ahead of its H1Jun16 interims.  2016 order book of  4.1m, 0.5mn lower than previously announced  due to  impact of Sterling orders & a revised customer order. The Board confirms it is beginning to see progress in an increasing order book & sales conversions. H1 revs €0.26m. Advances of €4.2m. Cash: €2.7m following £2m placing. Factory nearly complete. PE 16.4x.

 

Independent Oil & Gas (IOG.L) 29.12p £29.9m

The development and production focused Oil and Gas Company, announced the completion of its first operated appraisal well on the Skipper oil discovery which lies in Block 9/21a in licence P1609 in the Northern North Sea, of which IOG is 100% owner and operator.  Retrieved good quality reservoir condition oil samples from the Skipper reservoir in order to optimise the Skipper field development plan.  Secondary exploration target did not show hydrocarbons.

 

Alpha Real Trust (ARTL.L) 84.3p £58.4m

ART currently focuses on high-yielding property, infrastructure and asset backed debt and equity investments in Western Europe. Trading update to 30 Jun 2016. NAV per share increased to 141.7p at 30 June 2016 (137.9p: 31 March 2016). Adjusted earnings per share of 2.0p for the quarter ended 30 June 2016 (7.0p: 12 months to 31 March 2016) . Declaration of a dividend of 0.6p. Income from investments, both equity and high yield debt, continue to add to the Company´s earnings position .

 

Head Chef:

Derren Nathan
0203 764 2344
derren.nathan@hybridan.com

*A corporate client of Hybridan LLP

Disclaimer

This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.

Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, does not constitute “independent investment research” for the purposes of the Financial Conduct Authority rules. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, directors, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the UK, this document is directed at and is for distribution only to persons who (i) fall within Article 19(5) (persons who have professional experience in matters relating to investments) or Article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) or (ii) are Professional Clients or Eligible Counterparties (as those terms are defined in the rules of the Financial Conduct Authority) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as “relevant persons”). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by persons who would be classified as Retail Clients (as defined by the rules of the Financial Conduct Authority).

Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of UK or US securities law, or the law of any such other jurisdictions.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, directors, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

Neither the whole nor any part of this document may be duplicated in any form or by any means. Neither should this document, or any part thereof, be redistributed or disclosed to anyone without the prior consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX. If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.